Nexalin Technology (NXL) Interest Coverage Ratio Growth (1y) (2022 - 2026)
Nexalin Technology (NXL) Interest Coverage Ratio Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -54.61% |
| 10 | Nexalin Technology | 9.49 Mn | 6.78 Mn | 13,133.00 | 43.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.24% |
| Dec 31, 2025 | -97.42% |
| Sep 30, 2025 | 43.08% |
| Jun 30, 2025 | -20.08% |
| Mar 31, 2025 | -80.63% |
| Dec 31, 2024 | 1,959.38% |
| Sep 30, 2024 | -0.14% |
| Jun 30, 2024 | -47.92% |
| Mar 31, 2024 | 3.06% |
| Dec 31, 2023 | -423.18% |
| Sep 30, 2023 | -537.86% |
| Jun 30, 2023 | 27.04% |
| Mar 31, 2023 | -296.58% |
| Dec 31, 2022 | -270.93% |
| Sep 30, 2022 | 57.54% |